Guardian Pharmacy Services, Inc. $GRDN Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC trimmed its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) by 71.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,678 shares of the company’s stock after selling 94,215 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.08% of Guardian Pharmacy Services worth $1,539,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in GRDN. Braun Stacey Associates Inc. bought a new position in shares of Guardian Pharmacy Services in the 2nd quarter valued at $14,234,000. Ranger Investment Management L.P. bought a new stake in shares of Guardian Pharmacy Services during the second quarter worth about $7,263,000. Dimensional Fund Advisors LP increased its stake in shares of Guardian Pharmacy Services by 200.0% in the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock valued at $7,855,000 after buying an additional 139,070 shares during the period. Sei Investments Co. increased its stake in shares of Guardian Pharmacy Services by 40.5% in the first quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after buying an additional 103,177 shares during the period. Finally, First Trust Advisors LP acquired a new position in shares of Guardian Pharmacy Services in the first quarter valued at approximately $3,528,000.

Guardian Pharmacy Services Price Performance

Shares of GRDN stock opened at $48.83 on Thursday. The stock has a market capitalization of $3.09 billion, a PE ratio of 41.74, a PEG ratio of 2.63 and a beta of 0.06. The business’s 50 day simple moving average is $42.91 and its 200 day simple moving average is $39.06. Guardian Pharmacy Services, Inc. has a one year low of $26.34 and a one year high of $50.85.

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.02. Guardian Pharmacy Services had a net margin of 5.13% and a return on equity of 30.29%. The firm had revenue of $371.07 million for the quarter, compared to the consensus estimate of $365.76 million. As a group, research analysts expect that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on GRDN shares. KeyCorp began coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 price target for the company. Weiss Ratings raised shares of Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 9th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Saturday, November 14th. Truist Financial increased their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a report on Monday, September 21st. Finally, Oppenheimer raised their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. Nine research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $45.57.

Read Our Latest Stock Report on Guardian Pharmacy Services

Guardian Pharmacy Services Company Profile

(Free Report)

Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.

Featured Stories

Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report).

Institutional Ownership by Quarter for Guardian Pharmacy Services (NYSE:GRDN)

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.